4//SEC Filing
Gilmour Duncan 4
Accession 0001062993-25-005893
CIK 0001036262other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:31 PM ET
Size
17.2 KB
Accession
0001062993-25-005893
Insider Transaction Report
Form 4
INTEST CORPINTT
Gilmour Duncan
CFO, Treasurer & Secretary
Transactions
- Award
Common Stock
2025-03-17+10,767→ 57,168 total - Award
Common Stock
2025-03-17+10,767→ 67,935 total - Award
Employee Stock Option (right to buy)
2025-03-17$4.61/sh+1,992$9,183→ 1,992 totalExercise: $7.74Exp: 2035-03-16→ Common Stock (1,992 underlying) - Award
Employee Stock Option (right to buy)
2025-03-17+18,077→ 18,077 totalExercise: $7.74Exp: 2035-03-16→ Common Stock (18,077 underlying)
Holdings
- 8,104
Employee Stock Option (right to buy)
Exercise: $16.80Exp: 2031-06-13→ Common Stock (8,104 underlying) - 8,044
Employee Stock Option (right to buy)
Exercise: $16.06Exp: 2033-03-07→ Common Stock (8,044 underlying) - 12,848
Employee Stock Option (right to buy)
Exercise: $9.76Exp: 2032-03-08→ Common Stock (12,848 underlying) - 200(indirect: By Spouse)
Common stock
- 12,724
Employee Stock Option (right to buy)
Exercise: $11.33Exp: 2034-03-05→ Common Stock (12,724 underlying)
Footnotes (8)
- [F1]These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026.
- [F2]These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 17, 2028 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 16,151.
- [F3]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 in lieu of an annual base salary merit increase of $9,181. This option will vest in four equal annual installments commencing on March 17, 2026.
- [F4]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026.
- [F5]This option vests in four equal annual installments commencing on March 6, 2025.
- [F6]This option vests in four equal annual installments commencing on March 8, 2024.
- [F7]This option vests in four equal annual installments commencing on March 9, 2023.
- [F8]This option vests in four equal annual installments commencing on June 14, 2022.
Issuer
INTEST CORP
CIK 0001036262
Entity typeother
Related Parties
1- filerCIK 0001866719
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:31 PM ET
- Size
- 17.2 KB